Skip to main content

Ephedrine Facts

Stimulant; Substituted phenethylamine; Alpha/beta adrenergic receptor agonist

Description

Ephedrine is a naturally-occurring stimulant of the phenylpropanolamine class. It works by forcing norepinephrine into nerve junctions, amplifying the body's fight-or-flight response in the heart and brain.[1][2]

Subjective effects include stimulation, wakefulness, appetite suppression, mild euphoria,[3] and a noticeable increase in heart rate. The experience is closer to strong caffeine than to classical stimulants — cardiovascular activation dominates, with modest cognitive and mood effects.

Dependence liability is low,[4] but cardiovascular toxicity is the principal lethal risk — high doses can cause heart attacks, dangerous heart rhythms, and death. Tolerance builds quickly through norepinephrine depletion; the stimulant effect fades faster than the cardiovascular strain, making dose escalation dangerous.[5]

Dose and durationby route · individual sensitivity varies

Oral(mg)
Threshold< 10 mgLight15 – 25 mgCommon25 – 50 mgStrong50 – 75 mgHeavy75+ mg

Starts in 30 – 60 minLasts 3 – 6 hoursAfter-effects 2 – 6 hours

Body and dependence

Acute toxicity
Moderate
Chronic toxicity
Moderate
Physical dependence
Low
Psychological dependence
Low
Withdrawal
None recorded
Compulsive redosing
Low

Tolerance

Builds
Rapid
Fully resets after
Not recorded
Carries over to
other sympathomimetic amines; alpha-adrenergic agonists

Effectslikely at a common dose

Body
Respiratory stimulation; Stimulation; Vasoconstriction; Wakefulness; Pupil dilation; +14 possible, including Heart rate perception changes, Abnormal heartbeat, Excessive sweating
Feeling
none likely · 3 possible, including Anxiety

Who shouldn't take it

Absolute
Pheochromocytoma; Acute hypertension; Tachyarrhythmia; MAOI therapy (within 14 days)
Relative
Ischemic heart disease; Aortic stenosis; Psychotic disorders; Pregnancy; Urinary retention / prostatic hyperplasia

Combinations60 recorded

Lethal (1)
MAOIs
Dangerous (26)
Alpha-2 adrenergic receptor antagonist; Amphetamines; Caffeine; GHB, Baclofen; Local anesthetics; MDMA, Amphetamines; MDMA, MDA; NDRIs (Wellbutrin); NRIs; Opioids; SSRIs; Stimulants; 5-HTP, Tryptophan; Anticholinergics; Antipsychotics; Dopamine agonists; GHB, GBL; Ibogaine; Ketamine, DXM, PCP; Lithium; NSAIDs; Poppers (Alkyl nitrites); Psychedelics; Salvia, Ibogaine; and 2 more, see full page
Caution (30)
See full page: psychedex.org/substances/ephedrine
Not graded (3)
Not listed never means safe.

Seek help immediately if

  • Chest pain; racing, pounding, or irregular heartbeat
  • Very high body temperature; heavy sweating; hot, flushed skin
  • Severe agitation, paranoia, panic, or confusion
  • Severe headache; muscle rigidity or twitching
  • Seizures
  • Signs of stroke — face drooping, one-sided weakness, slurred speech
  • Difficulty breathing; collapse or unconsciousness

What to do

  1. Call emergency services for chest pain, overheating, seizure, or unresponsiveness
  2. Move them to a cool, quiet place and reduce stimulation
  3. Cool the body — remove excess clothing, apply cool damp cloths, fan them
  4. Keep them calm; reassure — panic worsens the cardiovascular strain
  5. If seizing, protect from injury (don't restrain); recovery position afterward
  6. Monitor breathing and be ready to give rescue breaths / CPR

Most stimulant overdoses settle with cooling, a calm environment, and time. The medical danger is hyperthermia, cardiac events (arrhythmia, heart attack, stroke), and seizures — get help immediately if any appear.

988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE

Version r1 · Not medical advice

References

  1. [1]
    ^Gad MZ, Azab SS, Khattab AR, Farag MA (2021) Over a century since ephedrine discovery: an updated revisit to its pharmacological aspects, functionality and toxicity in comparison to its herbal extracts. — Food & Function doi:10.1039/d1fo02093e
  2. [2]
    ^Kobayashi S, Endou M, Sakuraya F, Matsuda N, et al. (2003) The sympathomimetic actions of l-ephedrine and d-pseudoephedrine: direct receptor activation or norepinephrine release? — Anesthesia and Analgesia doi:10.1213/01.ane.0000092917.96558.3c
  3. [3]
    ^Chait LD (1994) Factors influencing the reinforcing and subjective effects of ephedrine in humans. — Psychopharmacology PMID:7862849
  4. [4]
    ^Miller SC (2005) Psychiatric effects of ephedra: addiction. — American Journal of Psychiatry PMID:16263877
  5. [5]
    ^Pickup ME, May CS, Ssendagire R, Paterson JW (1976) The pharmacokinetics of ephedrine after oral dosage in asthmatics receiving acute and chronic treatment. — British Journal of Clinical Pharmacology PMID:973934
Print version
Report an issue